"It gives me a great pleasure and privilege to write and edit this book titled "Long-term care of kidney transplant patients". I entered the kidney transplant field in 1983, the year Cyclosporine was approved for clinical use in the USA. Introduction of Cyclosporine resulted in a new era for kidney transplantation with marked reduction in rates of acute rejection leading to better short-term survival1. Improvement in long-term survival was first noted in 20002 and further steady improvements over next 20 years were ...
Read More
"It gives me a great pleasure and privilege to write and edit this book titled "Long-term care of kidney transplant patients". I entered the kidney transplant field in 1983, the year Cyclosporine was approved for clinical use in the USA. Introduction of Cyclosporine resulted in a new era for kidney transplantation with marked reduction in rates of acute rejection leading to better short-term survival1. Improvement in long-term survival was first noted in 20002 and further steady improvements over next 20 years were confirmed in 20213. It is difficult to ascertain specific reasons for improvements in long-term survival, but with advances over four decades, there are several potential reasons and are as follows:It gives me a great pleasure and privilege to write and edit this book titled "Long-term care of kidney transplant patients". I entered the kidney transplant field in 1983, the year Cyclosporine was approved for clinical use in the USA. Introduction of Cyclosporine resulted in a new era for kidney transplantation with marked reduction in rates of acute rejection leading to better short-term survival1. Improvement in long-term survival was first noted in 2002 and further steady improvements over next 20 years were confirmed in 2023. It is difficult to ascertain specific reasons for improvements in long-term survival, but with advances over four decades, there are several potential reasons and are as follows:"
Read Less
